Suggested Topics within your search.
Suggested Topics within your search.
-
24121
APPLICATION OF SOFT SETS TO ASSESSMENT OF MATHEMATICAL MODELLING SKILLS
Published 2022-01-01Get full text
Article -
24122
-
24123
-
24124
Competitive Variety Testing of winter common wheat in the conditions of the Penza region
Published 2023-07-01Get full text
Article -
24125
-
24126
-
24127
-
24128
Principles of Teachers’ Multicultural Competences Development in the Art Cycle Disciplines
Published 2024-10-01Get full text
Article -
24129
-
24130
-
24131
-
24132
Nonregular Physical Activity and Handgrip Strength as Indicators of Fatigue and Psychological Distress in Cancer Survivors
Published 2025-05-01“…Integrating strength assessments and structured physical activity programs may be key strategies in survivorship care to improve mental well-being and overall quality of life.…”
Get full text
Article -
24133
Specific features of current intraperitoneal therapy in patients with ovarian cancer
Published 2016-06-01Get full text
Article -
24134
-
24135
-
24136
PD‐L1 in gestational trophoblastic disease: an antibody evaluation
Published 2022-09-01Get full text
Article -
24137
-
24138
Community engagement in outbreak response: lessons from the 2014–2016 Ebola outbreak in Sierra Leone
Published 2020-08-01Get full text
Article -
24139
-
24140
Synergistic Induction of Immunogenic Cell Death by Biomineralized Manganese and Bisphosphonates Enhances Anti-PD-L1 Therapy in Triple-Negative Breast Cancer
Published 2025-04-01“…Xiuli Zhang,1,2,* Nan Liu,1,2,* Mingjing Wei,1,2 Chuanlai Yang,1,2 Yanhua Lin,1,2 Yarong Zeng,1,2 Yufang Li,1,2 Lizhi Zhou,1,2 Tingting Li,1,2 Qingbing Zheng,1,2 Hai Yu,1,2 Jun Zhang,1,2 Ying Gu,1,2 Ningshao Xia,1,2 Shaowei Li1,2 1State Key Laboratory of Vaccines for Infectious Diseases, XiangAn Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen, People’s Republic of China; 2National Institute of Diagnostics and Vaccine Development in Infectious Diseases, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Collaborative Innovation Center of Biologic Products, National Innovation Platform for Industry-Education Integration in Vaccine Research, The Research Unit of Frontier Technology of Structural Vaccinology of Chinese Academy of Medical Sciences, Xiamen, People’s Republic of China*These authors contributed equally to this workCorrespondence: Shaowei Li, Email shaowei@xmu.edu.cn Ying Gu, Email guying@xmu.edu.cnBackground: Despite therapeutic benefits of anti-Programmed Death-Ligand 1 (PD-L1) therapy in triple-negative breast cancer (TNBC), low response rates and resistance limit its efficacy. …”
Get full text
Article